Møiniche, M., Johansen, K.H., Parrón-Ballesteros, J. et al. Nat Commun 17, 2402 (2026). https://doi.org/10.1038/s41467-026-69134-4
Abstract
![]() |
| Mouse serum–mediated inhibition of human IgE binding to nsLTP allergens assessed by ELISA. |
A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology
Møiniche, M., Johansen, K.H., Parrón-Ballesteros, J. et al. Nat Commun 17, 2402 (2026). https://doi.org/10.1038/s41467-026-69134-4
Abstract
![]() |
| Mouse serum–mediated inhibition of human IgE binding to nsLTP allergens assessed by ELISA. |
Atopic dermatitis (AD) is frequently complicated by atopic keratoconjunctivitis (AKC), yet the cutaneous disease severity does not consistently parallel ocular involvement. This study investigated whether severe AKC is associated with circulating cytokine patterns distinct from those observed in patients with AD without severe ocular involvement (AD-only).
Serum samples were collected from four cohorts: healthy controls (n = 11), patients with AD-only (n = 11), patients with AKC (n = 11), and patients with Stevens-Johnson syndrome (SJS) with severe ocular complications (n = 15). Serum concentrations of 48 cytokines, chemokines, and growth factors were assessed using a multiplex bead-based immunoassay.
![]() |
| Comparison of serum cytokine levels between atopic and non-atopic ocular infammation. |
ABSTRACT
Background
In chronic spontaneous urticaria (CSU), exacerbations are often associated with aggravating factors. However, the prevalence of patients having aggravating factors has been insufficiently studied. This mHealth study aimed to (i) estimate the prevalence of patient-reported perceived aggravating factors for CSU across 10 countries, and (ii) identify factors associated with such triggers.
Methods
We performed a cross-sectional analysis of data from users of the CRUSE mobile application. The study included patients aged 15–74 years with self-reported CSU. We assessed the frequency of reporting at least one of the following perceived aggravating factors: stress, food, exercise, low or high temperature, rubbing of the skin, infection, and medication.
Bousquet J, Klimek L, Kuhl HC et al. Clin Transl Allergy. 2026 Nov;16(11):e70213. doi: 10.1002/clt2.70213.
ABSTRACT
Background
The aim of this study was to compare the onset of action (primary), and overall efficacy (secondary) of azelastine nasal spray 0.15% (AZE 0.15%) with mometasone/olopatadine combination therapy (OloMom) in subjects with allergen-induced rhinitis under controlled allergen exposure conditions in an Environmental Exposure Unit (EEU).
Method
This was a randomized, double-blind, placebo-controlled, three-period Williams cross-over study. Participants were randomized to receive AZE 0.15%, OloMom, or placebo. Efficacy was assessed during two pollen challenge sections in an EEC, after a single dose and after 3.5 days of treatment.
Xu Y, Gao Y, Long Y, Wang C et al. Patient Prefer Adherence. 2026 Oct 22;20:641358. doi: 10.2147/PPA.S641358.
Background: Rush subcutaneous immunotherapy (RIT) requires frequent injections, strict treatment intervals, and long-term follow-up. Digital management integrates injection scheduling, reminders, treatment records, and patient-reported follow-up.
Objective: This study aimed to evaluate the association of a digital immunotherapy management system with adherence and clinical outcomes in patients undergoing RIT.
![]() |
| Graphical Abstract |
Abstract
Background
Allergic rhinitis (AR) is a common chronic nasal mucosal inflammation with limited treatment options. IRAK2 regulates allergic airway inflammation, but its expression, clinical value, and mechanism in AR remain unexplored. This study screened AR-related candidate genes using bioinformatics, verified serum IRAK2 expression and its clinical significance in AR patients, and explored its functional mechanism in vitro.
Methods
GEO datasets were used to screen differentially expressed genes and candidate genes related to AR. Serum samples were collected from 100 AR patients and 100 healthy controls. Serum IRAK2 levels were detected, and correlation analysis, ROC curve analysis and logistic regression analysis were performed.